Evidence‐based nutritional and lifestyle strategies play a pivotal role to address key challenges around GLP‐1 treatment of obesity, making clinicians more effective in advancing their patients' health. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.